⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELUT News
Elutia Inc. Class A Common Stock
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
globenewswire.com
ELUT
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
globenewswire.com
ELUT
BSX
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
globenewswire.com
ELUT
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
ELUT
Form 8-K
sec.gov
ELUT
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
globenewswire.com
ELUT
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
globenewswire.com
ELUT
Form 8-K
sec.gov
ELUT
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
globenewswire.com
ELUT
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
globenewswire.com
ELUT